Metoprolol controlled release - Beijing CoSci Med Tech
Latest Information Update: 06 Oct 2021
At a glance
- Originator Beijing CoSci Med-Tech
- Class Antihypertensives; Antimigraines; Class II antiarrhythmics; Heart failure therapies; Ischaemic heart disorder therapies; Propanolamines
- Mechanism of Action Beta 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Heart failure; Hypertension
Most Recent Events
- 05 Aug 2016 Chemical structure information added
- 22 Jul 2016 Investigation in Heart failure in China (PO)
- 22 Jul 2016 Investigation in Hypertension in China (PO)